Premium
The effects of short‐term treatment of microcystin‐LR on the insulin pathway in both the HL7702 cell line and livers of mice
Author(s) -
Huang Pu,
Chen Kele,
Ma Tianfeng,
Cao Naifang,
Weng Dengpo,
Xu Chun,
Xu Lihong
Publication year - 2020
Publication title -
environmental toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.813
H-Index - 77
eISSN - 1522-7278
pISSN - 1520-4081
DOI - 10.1002/tox.22907
Subject(s) - chemistry , protein kinase b , glycogen synthase , hyperphosphorylation , protein phosphatase 2 , medicine , endocrinology , phosphatase , gsk 3 , phosphorylation , intraperitoneal injection , alkaline phosphatase , hepatocyte , glycogen , signal transduction , biochemistry , biology , enzyme , in vitro
Our previous work indicated exposure of Human liver cell 7702 (HL7702) cells to Microcystin‐leucine‐arginine (MC‐LR) for 24 hours can disrupt insulin (INS) signaling by the hyperphosphorylation of specific proteins. For further exploring the time‐dependent effect posed by MC‐LR on this pathway, in the current study, HL7702 cells together with mice were exposed to the MC‐LR with different concentrations under short‐term treatment, and then, protein phosphatase 2A (PP2A) activity and expression of proteins related to INS signaling, as well as the characteristics of their action in the liver, were investigated. The results indicated, in HL7702 cells with 0.5, 1, and 6 hours of treatment by MC‐LR, PP2A activity showed an obvious decrease in a time and concentration‐dependent manner. While the total protein level of Akt, glycogen synthase kinase 3 (GSK‐3), and glycogen synthase remained unchanged, GSK‐3 and Akt phosphorylation increased significantly. In livers of mice with 1 hour of intraperitoneal injection with MC‐LR, a similar change in these proteins was observed. In addition, the levels of total IRS1 and p‐IRS1 at serine sites showed decreasing and increasing trends,respectively, and the hematoxylin and eosin staining showed that liver tissues of mice in the maximum‐dose group exhibited obvious hepatocyte degeneration and hemorrhage. Our results further proved that short‐term treatment with MC‐LR can inhibit PP2A activity and disrupt INS signaling proteins' phosphorylation level, thereby interfering with the INS pathway. Our findings provide a helpful understanding of the toxic effects posed by MC‐LR on the glucose metabolism of liver via interference with the INS signaling pathway.